Solventum Corp reported $523M in EBITDA for its fiscal quarter ending in September of 2026.





Ebitda Change Date
Abbott USD 2.43B 844M Mar/2026
Align Technology USD 232.86M 3.72M Jun/2026
Baxter International USD 474M 165M Jun/2026
Becton, Dickinson and Co. USD 1.71B 1B Jun/2026
Cencora USD 1.39B 15.27M Jun/2026
Dexcom USD 435.2M 46.5M Sep/2026
Insulet USD 233.7M 33.9M Sep/2026
Solventum Corp USD 523M 147M Sep/2026
West Pharmaceutical Services USD 267.4M 23.8M Sep/2026
Zimmer Biomet Holdings USD 634.8M 195.7M Sep/2026